Abstract
255 Peroral use of vaccinia virus. Results and prospects: V.N.Podkuiko, A.A.Vorobicv, V.P.Krasnianskiy, G.T.Patrykecv, V.V.Mikhailov, T.V.Dorokhina, A.A.Makhlay, and G.A.Dikanov. Virological Centre of Microbiological Research Institute of the Defence Ministry, Sergiev Posad, Russia
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
